DISEASE CANCELLING

Welcome to the Brand page for “DISEASE CANCELLING”, which is offered here for Disease;drug discovery services provided through a computer software platform used for research and development in the field of drugs; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; providing medical and scientific research information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials via the internet; research and development of new products; medical and scientific research in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; platform as a service (paas) featuring computer software platforms using biology and chemistry analytics for determining drug candidates with reduced toxicity; platform as a service (paas) featuring computer software platforms for database mining, database analysis, database management and the application of artificial intelligence; consultancy in relation to the development and implementation of software and software based applications;.

Its status is currently believed to be active. Its class is unavailable. “DISEASE CANCELLING” is believed to be currently owned by “Immuneering Corporation”.


Owner:
IMMUNEERING CORPORATION
Owner Details
Description:
DISEASE;drug discovery services provided through a computer software platform used for research and development in the field of drugs; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; providing medical and scientific research information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials via the internet; research and development of new products; medical and scientific research in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; platform as a service (PAAS) featuring computer software platforms using biology and chemistry analytics for determining drug candidates with reduced toxicity; platform as a service (PAAS) featuring computer software platforms for database mining, database analysis, database management and the application of artificial intelligence; consultancy in relation to the development and implementation of software and software based applications;
Categories: DISEASE